Overview

Oxytocin Administration in BDD and OCD

Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the current study is to investigate the effect of an acute administration of intranasal oxytocin, relative to placebo, on social cognitive impairments among individuals with body dysmorphic disorder and obsessive-compulsive disorder, compared to healthy controls.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Oxytocin